Clinical Trial

The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn how GLP-1 and GIP agonists effect bowel preparation in patients scheduled for colonoscopies. The main questions it aims to answer are: * Does GLP-1 and GIP agonist increase the rate of inadequate bowel preparation? * Does the quality of bowel preparation differ in patients who hold vs. those who continue a single dose of their GLP-1 or GIP agonist medication? * Are there any differences in the rates of complications gastric aspiration in patients who hold vs. continue a single dose of their GLP-1 or GIP agonist medication?
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-11.
Trial Details
NCT Number NCT07127354
Lead Sponsor The Cleveland Clinic
Conditions GLP - 1, Bowel Preparation for Colonoscopy
Enrollment 132 participants
Start Date 2025-08-01
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-12-04